Lates News

According to Every AI Express, Dongwu Securities issued a research report on August 26, giving Lepu Medical Technology (300206.SZ) a buy rating. The main reasons for the rating include: 1) The company's main business in the first half of 2025 is stable, with a steady gross profit margin; 2) Both domestic and foreign revenue of the company improved on a quarter-on-quarter basis in the second quarter of 2025. (Daily Economic News)